Compass Therapeutics Provides Corporate Update : vimarsana.c

We continue to open clinical sites and enroll patients in COMPANION-002, the Phase 2/3 randomized study of CTX-009 in patients with advanced biliary tract cancer . Consistent with prior guidance, top...

Related Keywords

Boston , Massachusetts , United States , Vered Bisker Leib , Thomas Schuetz , Danna Gifford , Carl Gordon , Compass Therapeutics Inc , Exchange Commission , Nasdaq , Globenewswire Inc , Development Pipeline Updates , Compass President , Compass Chief Executive Officer , Compas Scientific Founder , Chief Executive Officer , Vice Chair , Pipeline Updates , Adaptive Simon Two Stage , Annual Report , Quarterly Report , Communications Manager , Markets ,